Brewin Dolphin has a market leading presence in healthcare and its related services based around the Extel rated No.1 Healthcare team (Small cap Extel survey, 2009). The team has brought propositions such as Caretech plc to the market and identified recommendations that have delivered consistent performance and high earnings visibility. The team has been equally active in mergers and acquisitions, advising AIM listed Synergy Healthcare plc on the £180m acquisition of Fully Listed Isotron plc, expanding the Group’s infection control services into gamma irradiation.

We believe that the Healthcare sector will continue to have the support of investors due to its positive long term demographics.